About: pharmaceutical companies

Health 03-07-2018

EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation

The next European Commission should focus on the bloc’s role in the global context of innovation, as China is “decisive” about creating a reliable framework for intellectual property and connecting biotech start-ups and digital companies, EFPIA’s President Stefan Oschmann told EURACTIV.com in an interview.  
Health 28-05-2018

Roche CEO: US, China dominate healthcare innovation, EU lags ‘far behind’

The US is leading in healthcare innovation, China is catching up at high speed and Europe is just watching the global developments, Roche CEO Severin Schwan warned on Monday (28 May). EURACTIV.com reports from Dublin.
Health 07-05-2018

Pharma boss: Incentives based on outcomes will optimise EU healthcare

An outcomes-based approach for incentives in the pharmaceutical sector would help optimise the entire healthcare systems, Nathalie Moll told EURACTIV.com in an interview.
Health 30-03-2018

Generic industry boss: SPC manufacturing waiver won’t harm originators’ innovation

The generic industry’s request for an SPC (supplementary protection certificates)  manufacturing waiver, which would allow them to produce in the EU SPC-protected drugs for other markets, does not influence or harm innovators’ rights, Marc–Alexander Mahl told EURACTIV.com in an interview. He...
Development Policy 28-03-2018

Africa takes steps to make medicine more affordable

Faced with the numerous difficulties of access to medicine in Africa, African states want to organise the market to increase local production, which currently accounts for 3% of world output.
Brexit 21-03-2018

‘Vital’ UK remains part of EU clinical trials, say MPs

Continued participation in EU-wide clinical trials and the Horizon 2020 research programme is ‘vital’ to the UK’s life sciences sector, according to a new cross-party report by UK MPs.
Brexit 14-03-2018

NHS faces ‘serious challenges’ from Brexit, warns new report

Brexit poses “serious challenges” to the NHS in the form of longer waiting times, staff shortages and delays in the approval of new medicines, according to a report published on Wednesday (14 March).
Health 16-02-2018

Greek judges call for calm over Novartis scandal

The Greek Union of Judges and Prosecutors called for “calmness and sobriety” on Friday (16 February), following a lawsuit by former Prime Minister Antonis Samaras against Premier Alexis Tsipras and Prosecutor of Corruption Eleni Touloupaki over the Novartis scandal.
Health 06-02-2018

Pharma scandal whips up political storm in Greek opposition ranks

A probe into illegal practices of Swiss drugmaker Novartis in Greece, involving thousands of state officials and doctors, has opened the Pandora’s Box in Greek politics as local media have named ten former bigwigs from opposition parties as being targeted by the investigation.
Health 24-01-2018

Health tech bill to kick off busy policy agenda in 2018

The European Commission will propose a new law on Health Technology Assessments to kick off a busy EU health agenda in 2018.
Health 08-12-2017

Drug pricing debate to take place in heated atmosphere

Following a Greek government request, the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) will discuss on Friday (8 December) a recent dispute between Athens and ROCHE, a Swiss multinational company, over the latter’s decision to withdraw a cancer drug from the market.
Health 13-10-2017

New Commission study fuels generic drugs industry ‘manufacturing dispute’

The European Commission launched on Thursday (12 October) a public consultation on supplementary protection certificates for pharmaceutical products and the so-called Bolar patent research exemption.
Health 11-07-2017

Dutch health minister: EMA relocation is not entertainment, listen to the Commission

The European Medicines Agency (EMA) is not a toy to be played with by politicians, Edith Schippers told EURACTIV.com. The decision on the agency's relocation should be based on the European Commission's assessment, she argues in an interview.
Health 05-07-2017

Drug agency relocation talks divide old and new EU members

The debate over where to relocate the London-based European Medicines Agency (EMA) after Brexit has divided the other 27 EU member states, despite calls for an urgent decision from the drugs industry and patient groups.
Brexit 26-04-2017

Drugs firms call for phased transition of regulation after Brexit

Pharmaceutical companies called on Thursday (27 April) for a phased transition in drug regulation after Britain leaves the European Union, in order to avoid supply disruption and protect public health.
Health 24-04-2017

Ghana, Kenya and Malawi to pilot GSK malaria vaccine from 2018

Ghana, Kenya and Malawi will pilot the world's first malaria vaccine from 2018, offering it for babies and children in high-risk areas as part of real-life trials, the World Health Organization said today (24 April).
Health 10-04-2017

London wants to protect free movement of talent after Brexit

Controls on EU immigration played a key role in the Brexit vote. However, the UK government now says that it wants to protect the free movement of researchers and talent, which are crucial for the life sciences sector. EURACTIV.com reports from Lyon.
Health 22-02-2017

Greek pharma boss: Patients are punished when innovation is penalised

Patients are “punished” due to a lack of innovation-driven structural reforms in a crisis-hit public health system, the head of the Greek pharma industry said in an interview with Euractiv Greece.
Health 29-09-2016

Fake drugs cost EU billions of euros, its health and its jobs

Counterfeit drugs are not only hazardous to health, they cost people their jobs too, a new EU study has revealed. But Germans in particular are willing to take risks. EURACTIV's partner Der Tagesspiegel reports.
Health 28-09-2016

Parliament wants harmonised criteria for drug pricing and reimbursement

The European Parliament will seek an increased EU role in regulating the pharmaceutical market and controlling rising drug prices, according to a draft report seen by EURACTIV.com.
Health 19-09-2016

Pharma industry ‘cannot escape’ drug price talks, say patient groups

Patient groups and the pharmaceutical sector agree that access to medicines needs to be improved - but the way to do it seems to divide them. EURACTIV.com reports from Sofia.
Health 16-09-2016

Antimicrobial resistance ‘high on political agenda’, EU claims

The European Commission is determined to further strengthen its antimicrobial resistance action for the period beyond 2016, an EU official has told EURACTIV.com, dismissing allegations that the EU executive lacks the political will to do so.
Health 01-08-2016

EU drugs agency to unveil results on ‘early medicines’ project this week

The European Medicines Agency (EMA) will this week publish the much-awaited results of a pilot project on the early marketing authorisation of drugs, EURACTIV has learnt.
Health 26-07-2016

Pharma expert: new ‘value added medicines’ offer cheaper, customised treatment

A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com